---
title: "Schweiger Dermatology Group offers same-week appointments, and advanced skin cancer treatment; announces a landmark year of growth and innovation with 2.5 million patients served."
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/268811133.md"
description: "In New York on December 5, 2025, Schweiger Dermatology Group revealed a highly successful year marked by substantial growth, pioneering advancements in skin cancer treatment, and exceptional patient availability. As one of the leading dermatology practices in the country, the group has experienced rapid expansion, boasting over 2.5..."
datetime: "2025-12-05T23:41:39.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/268811133.md)
  - [en](https://longbridge.com/en/news/268811133.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/268811133.md)
---

# Schweiger Dermatology Group offers same-week appointments, and advanced skin cancer treatment; announces a landmark year of growth and innovation with 2.5 million patients served.

In New York on December 5, 2025, Schweiger Dermatology Group revealed a highly successful year marked by substantial growth, pioneering advancements in skin cancer treatment, and exceptional patient availability. As one of the leading dermatology practices in the country, the group has experienced rapid expansion, boasting over 2.5...

## Related News & Research

- [Social media bans on teens risk strengthening Big Tech's grip on the sector, Bluesky exec warns](https://longbridge.com/en/news/288921304.md)
- [Tesla's IPO minted 'Teslanaires.' Can SpaceX do the same?](https://longbridge.com/en/news/288933639.md)
- [The SpaceX IPO Is the Biggest in History. That Doesn't Automatically Make It a Good Investment.](https://longbridge.com/en/news/288927862.md)
- [Can SpaceX live up to Wall Street's multitrillion-dollar hype?](https://longbridge.com/en/news/288931769.md)
- [Novo's Wegovy Pill Isn't Just Beating Expectations -- It's Obliterating Them. Is the Beaten-Down Stock a Buy Now?](https://longbridge.com/en/news/288933490.md)